Listed

Pfizer Inc: Form 10-K for the period ended Dec 31, 2022

Filed with the SEC on Feb 23, 2023 and accepted by EDGAR at Feb 23, 2023, 14:12 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue12 months2022-01-01 to 2022-12-31$34.34bnus-gaap:CostOfGoodsAndServicesSold
Selling, general and administrative12 months2022-01-01 to 2022-12-31$13.68bnus-gaap:SellingGeneralAndAdministrativeExpense
Interest expense12 months2022-01-01 to 2022-12-31$1.24bnus-gaap:InterestExpense
Income tax12 months2022-01-01 to 2022-12-31$3.33bnus-gaap:IncomeTaxExpenseBenefit
Net income12 months2022-01-01 to 2022-12-31$31.37bnus-gaap:NetIncomeLoss
Diluted EPS12 months2022-01-01 to 2022-12-31$5.47us-gaap:EarningsPerShareDiluted
Basic EPS12 months2022-01-01 to 2022-12-31$5.59us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2022-01-01 to 2022-12-315,733,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2022-01-01 to 2022-12-31$29.27bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2022-01-01 to 2022-12-31$3.24bnus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases12 months2022-01-01 to 2022-12-31$2.00bnus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2022-12-31$416.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-12-31$51.26bnus-gaap:AssetsCurrent
Total assetsAt period end2022-12-31$197.21bnus-gaap:Assets
Current liabilitiesAt period end2022-12-31$42.14bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-12-31$101.29bnus-gaap:Liabilities
Long-term debtAt period end2022-12-31$32.88bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2022-12-31$2.56bnus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2022-12-31$95.66bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000078003-23-000024. Last ingested by Listed: Nov 12, 2026, 18:08 ET. Listed shows no prices and gives no investment advice.